Download full report with analyst certification and important disclosures
Oct 29 2026, 10:14 GMT
While CRH’s Q3 results are slightly ahead of our expectations, FY26 guidance has been lowered, with the new midpoint broadly in line with our current expectations. The company has launched a new multi-year $6bn buyback programme and a transformation initiative aimed at delivering $400m in annual benefits by the end of 2028. The stock remains cheap at current levels, and we reiterate our ‘Outperform’ rating.
Oct 29 2026, 10:14 GMT